Oct 13, 2026 06:46AM
Oct 6, 2026 07:35AM
Sep 28, 2026 06:57AM
Sep 25, 2026 07:00PM
Sep 25, 2026 07:00PM
Sep 22, 2026 08:31AM
Sep 22, 2026 08:30AM Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte’s Inflammation and Autoimmunity Portfolio
Sep 20, 2026 04:00PM
Sep 20, 2026 04:00PM
Aug 27, 2026 06:00PM
Aug 27, 2026 07:06AM
Jul 28, 2026 07:00AM
Jul 13, 2026 04:00AM
Jul 13, 2026 04:00AM Incyte Presents Phase 1/2 Multidose Data for VGA039 (Latarcibart) at ISTH 2026, Showing Substantial Bleed Reductions in Patients with all Von Willebrand Disease Types
Jul 6, 2026 08:39AM
Jul 6, 2026 08:39AM
Jun 26, 2026 09:00AM
Jun 26, 2026 09:00AM
Jun 19, 2026 02:00AM
Jun 15, 2026 09:24AM
Jun 14, 2026 04:35PM Mirum and Incyte report positive phase 2 results for FOP treatment
Jun 14, 2026 04:35PM
Jun 13, 2026 06:01AM
Jun 13, 2026 06:00AM
Jun 8, 2026 07:00AM
Jun 8, 2026 07:00AM
Jun 4, 2026 08:06AM
Jun 4, 2026 08:05AM Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026
Jun 1, 2026 02:53AM
May 30, 2026 08:00AM
May 12, 2026 09:30AM
May 7, 2026 08:50AM
May 7, 2026 08:50AM
May 3, 2026 12:00PM
May 1, 2026 05:28PM FDA approves Incyte's once-daily Jakafi XR for blood disorders
May 1, 2026 05:28PM
Apr 29, 2026 10:15AM
Apr 28, 2026 07:00AM
Apr 28, 2026 07:00AM
Apr 28, 2026 07:00AM
Apr 23, 2026 05:48AM
Apr 23, 2026 03:00AM MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia
Apr 21, 2026 10:00AM
Apr 21, 2026 10:00AM
Apr 7, 2026 12:26PM
Apr 7, 2026 07:30AM
Apr 2, 2026 07:01AM
Apr 2, 2026 07:01AM
Mar 30, 2026 10:19AM William Blair on Incyte (INCY): 'encouraged' by Ph3 data and deepened responses
Mar 30, 2026 04:21AM

334,267 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All